GALECTIN THERAPEUTICS INC — Director's Dealing 2013

May 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-04-29

Reporting Person: Shlevin Harold H. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-29	Common Stock	M	100000	$2.32	Acquired	100000	Direct
2013-04-29	Common Stock	F	46586	$4.98	Disposed	53414	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-29	Stock Option (right to buy)	$2.32	M	100000	Disposed	2022-08-27	Common Stock (100000)	Direct

Footnotes

F1: Stock options vest as follows: 50,000 shares vested on August 27, 2012, 50,000 shares vested on December 31,2012, 75,000 shares will vest on December 31, 2013, and 75,000 shares will vest on December 31, 2014.